Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: A randomized controlled split-face trial

Journal of Dermatology

Volumn 37, Issue 4, 2010, Pages 311-315

  Huh, Sun Young ^a   Shin, Jung Won ^a   Na, Jung Im ^a   Huh, Chang Hun ^a   Youn, Sang Woong ^a   Park, Kyoung Chan ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Liposome encapsulated 4 n butylresorcinol; Melasma; Randomized controlled trial; Split face design; Treatment

Indexed keywords

4 N BUTYLRESORCINOL; DERMATOLOGICAL AGENT; DRUG VEHICLE; LIPOSOME; MELANIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHLOASMA; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT SATISFACTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CAPSULES; DOSAGE FORMS; FEMALE; HUMANS; KOREA; LIPOSOMES; MELANOSIS; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; OXIDOREDUCTASES; PATIENT SATISFACTION; RESORCINOLS; TREATMENT OUTCOME;

EID: 77950252243     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00787.x     Document Type: Article

References (18)

1. Hearing VJ, Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 1991 5 : 2902 2909.
2. Kobayashi T, Urabe K, Winder A et al. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994 13 : 5818 5825.
3. Okubo T, Oyobikawa M, Futaki K, Matsukami M, Fujii A. The inhibitory effects of 4-n-butylresorcinol on melanogenesis. J Dermatol Sci 1995 10 : 88.
4. Tasaka K, Kamei C, Nakano S, Takeuchi Y, Yamato M. Effects of certain resorcinol derivatives on the tyrosinase activity and the growth of melanoma cells. Methods Find Exp Clin Pharmacol 1998 20 : 99 109.
5. Katagiri T, Okubo T, Oyobikawa M, Futaki K, Shaku M, Kawai M. Novel melanogenic enzymes for controlling hyperpigmentation. 20th IFSCC International Congress 1998 39 : 1 11.
6. Shimizu K, Kondo R, Sakai K. Inhibition of tyrosinase by flavonoids, stilbenes and related 4-substituted resorcinols: structure-activity investigations. Planta Med 2000 66 : 11 15.
7. Kim DS, Kim SY, Park SH et al. Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis. Biol Pharm Bull 2005 28 : 2216 2219.
8. Akasaka T, Ohurazaka H, Nishioheda G, Matsumoto S, Takenouchi M. Topically applied 0.3% 4-n-butylresorcinol decreases pigmentation after laser therapy. Environ Derm 2002 9 : 11 15.
9. Researching Committee of Rucinol®. The study on the efficacy of Rucinol® (4-n-butylresorcinol) in chloasma. Nishinihon J Dermatol 1999 61 : 813 819.
10. Khemis A, Kaiafa A, Queille-Roussel C, Duteil L, Ortonne JP. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol 2007 156 : 997 1004.
11. Cassano N, Alessandrini G, Mastrolonardo M, Vena GA. Peeling agents: toxicological and allergological aspects. J Eur Acad Dermatol Venereol 1999 13 : 14 23.
12. De Leeuw J, De Vijlder HC, Bjerring P, Neumann HA. Liposomes in dermatology today. J Eur Acad Dermatol Venereol 2009 23 : 505 516.
13. Artmann C, Roding J, Ghyczy M. Influence of various liposome preparations on skin humidity. Parfum Kosm 1990 90 : 326.
14. Anstey A, Quigley M, Wilkinson JD. Topical evening primrose oil as treatment for atopic dermatitis. J Dermatol Treat 1990 1 : 199 201.
15. Kanehara S, Ohtani T, Uede K, Furukawa F. Clinical effects of undershirts coated with borage oil on children with atopic dermatitis: a double-blind, placebo-controlled clinical trial. J Dermatol 2007 34 : 811 815.
16. Schmid MH, Korting HC. Liposomes: a drug carrier system for topical treatment in dermatology. Crit Rev Ther Drug Carrier Syst 1994 11 : 97 118.
17. Dreher F, Walde P, Luisi PL, Elsner P. Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes. Skin Pharmacol 1996 9 : 124 129.
18. Date AA, Naik B, Nagarsenker MS. Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol 2006 19 : 2 16.